$0.8204
-0.03-3.12%
Pre-Market: 5:19 PM EDT
Comments
Loading...
Renovaro (RENB) Forecast
NewsEarningsRenovaro (RENB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRenovaro (NASDAQ:RENB) Stock Quotes, Forecast and News Summary
Renovaro Stock (NASDAQ: RENB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Renovaro (RENB) stock?
You can purchase shares of Renovaro (NASDAQ:RENB) through any online brokerage.
Who are Renovaro (RENB) competitors?
Other companies in Renovaro’s space includes: Atossa Therapeutics (NASDAQ:ATOS), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX), TScan Therapeutics (NASDAQ:TCRX) and Lexeo Therapeutics (NASDAQ:LXEO).
What is the forecast, or price target, for Renovaro (RENB) stock?
There is no analysis for Renovaro to provide a consensus price target.
What is the current price for Renovaro (RENB)?
The stock price for Renovaro (NASDAQ: RENB) is $0.8204 last updated February 20, 2025 at 5:19 PM EST.
Does Renovaro (RENB) pay a dividend?
There are no upcoming dividends for Renovaro.
When is Renovaro (NASDAQ:RENB) reporting earnings?
Renovaro’s Q3 earnings are confirmed for Wednesday, May 14, 2025.
Is Renovaro (RENB) going to split?
There is no upcoming split for Renovaro.
What sector and industry does Renovaro (RENB) operate in?
Renovaro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.